The SCN4A gene hyperkalemic periodic paralysis genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SCN4A gene, which are associated with hyperkalemic periodic paralysis (HyperPP). HyperPP is a rare genetic disorder characterized by episodes of muscle weakness or paralysis, often triggered by elevated potassium levels in the blood. The condition is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the gene can cause the disorder.
This test is crucial for individuals who exhibit symptoms of HyperPP or have a family history of the condition, as it can provide a definitive diagnosis. Early identification of the disorder is vital for managing symptoms, preventing potential complications, and making informed decisions about family planning.
The test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the SCN4A gene hyperkalemic periodic paralysis genetic test is 4400 AED. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SCN4A gene.
Upon completion, the results can offer critical insights into the genetic underpinnings of the individual's condition, enabling personalized treatment plans and lifestyle adjustments to better manage the symptoms of hyperkalemic periodic paralysis.
The GCH1 Gene Hyperphenylalaninemia BH4-Deficient B Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the GCH1 gene, which are associated with BH4-deficient Hyperphenylalaninemia (HPA) type B. This condition is a rare metabolic disorder characterized by elevated levels of phenylalanine in the blood, due to a deficiency in tetrahydrobiopterin (BH4), a cofactor essential for the metabolism of several amino acids, including phenylalanine. Early detection and treatment are crucial to prevent developmental delays and neurological issues associated with the condition.
The test involves analyzing the patient's DNA to identify any genetic variations in the GCH1 gene that may lead to the dysfunction of BH4 synthesis. It is a critical tool for clinicians in the diagnosis and management of patients with suspected BH4-deficient Hyperphenylalaninemia, allowing for timely intervention and personalized treatment plans.
DNA Labs UAE offers this comprehensive genetic testing service at a cost of 4400 AED. The test is conducted in their state-of-the-art facilities, ensuring high-quality, reliable results for patients and healthcare providers.
The CACNA1S gene hypokalemic periodic paralysis type 1 genetic test is a specialized diagnostic tool used to identify mutations in the CACNA1S gene, which are linked to hypokalemic periodic paralysis type 1 (HypoPP1). This condition is characterized by episodes of muscle weakness or paralysis, often triggered by factors such as rest after exercise, high carbohydrate meals, or stress, due to abnormally low levels of potassium in the blood (hypokalemia). The test is crucial for confirming the diagnosis, allowing for appropriate management and treatment strategies to be implemented.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test involves analyzing the patient's DNA sample, typically collected through a blood draw, to search for specific genetic alterations in the CACNA1S gene known to cause the disorder. The presence of these mutations can confirm the diagnosis of HypoPP1, enabling affected individuals and their families to receive tailored advice on managing the condition, including preventive measures for avoiding triggers and potential treatments to alleviate symptoms.
The cost of the CACNA1S gene hypokalemic periodic paralysis type 1 genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the CACNA1S gene and provide individuals with reliable results. By opting for this test, patients gain crucial insights into their condition, empowering them with the knowledge needed to manage their health effectively.
The "DARS Gene Hypomyelination with Brainstem and Spinal Cord Involvement and Leg Spasticity Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the DARS gene. These mutations are known to cause a rare neurological disorder characterized by underdevelopment of the myelin sheath (hypomyelination) in the brainstem and spinal cord, leading to symptoms such as leg spasticity, difficulty in movement, and other related neurological impairments. The test is crucial for early diagnosis and management of the condition, providing essential genetic information that can guide treatment options and inform family planning decisions. Priced at 4400 AED, this genetic test represents a significant step forward in the personalized care and management of patients with this rare condition, offering hope for improved quality of life through targeted interventions.
The GNE Gene Inclusion Body Myopathy Genetic Test is a specialized diagnostic tool used to detect mutations in the GNE gene, which are responsible for a rare genetic disorder known as Inclusion Body Myopathy 2 (IBM2), also referred to as GNE Myopathy or Nonaka Myopathy. This condition is characterized by progressive muscle weakness and wasting, primarily affecting the lower limbs initially and then progressing to involve upper limbs and other muscle groups.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. By analyzing a patient's DNA sample, usually obtained through a blood draw, the test identifies specific mutations in the GNE gene that cause the disorder. This precise genetic insight is crucial for confirming a diagnosis, which can then guide treatment decisions, inform patients about the progression of the disease, and help families understand the risk of inheritance.
The cost of the GNE Gene Inclusion Body Myopathy Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem steep, the value of obtaining a definitive diagnosis and the potential to tailor a patient's care plan specifically to their genetic makeup makes it a worthwhile investment for those affected by this condition. Early diagnosis through genetic testing can significantly impact the management of the disease and improve the quality of life for individuals with GNE Myopathy.
The MYH2 gene inclusion body myopathy genetic test is a specialized diagnostic tool used to identify mutations in the MYH2 gene, which are associated with a rare form of muscle disease known as inclusion body myopathy. This condition is characterized by progressive muscle weakness and wasting, particularly affecting the muscles closest to the center of the body. Early and accurate diagnosis through genetic testing is crucial for managing the symptoms and planning appropriate treatment strategies.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to detect specific mutations in the MYH2 gene that are linked to the development of inclusion body myopathy. The process is highly precise, offering individuals and their healthcare providers valuable insights into the genetic underpinnings of the condition.
The cost of the MYH2 gene inclusion body myopathy genetic test at DNA Labs UAE is 4400 AED. While the price may seem high, the test provides essential information for the proper diagnosis and management of the condition, potentially improving the quality of life for those affected. Patients considering this test are advised to consult with their healthcare provider to discuss its benefits and implications fully.
The PLA2G6 Gene Infantile Neuroaxonal Dystrophy Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the PLA2G6 gene, which are linked to Infantile Neuroaxonal Dystrophy (INAD) Type 1. INAD Type 1 is a rare, inherited neurodegenerative disorder that typically manifests in early childhood, characterized by progressive loss of motor skills and intellectual abilities, leading to severe physical and mental disabilities. The condition is attributed to abnormalities in the PLA2G6 gene, which plays a crucial role in the maintenance of neuronal health.
This genetic test is conducted by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The test involves analyzing the patient's DNA, obtained through a blood sample, to detect mutations in the PLA2G6 gene that are responsible for INAD Type 1. The outcome of this test can provide crucial information for the diagnosis, management, and understanding of the disease's progression, offering families and healthcare providers valuable insights into the condition.
The cost of the PLA2G6 Gene Infantile Neuroaxonal Dystrophy Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to accurately identify the genetic mutations associated with the disorder, offering a critical step towards the appropriate care and support for affected individuals and their families.
The SCN9A gene insensitivity to pain channelopathy-associated genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SCN9A gene. This gene is crucial for the proper functioning of nerve cells involved in the sensation of pain. Mutations in the SCN9A gene can lead to a rare condition where individuals may not feel pain, known as hereditary sensory and autonomic neuropathy type II (HSAN II) or more broadly, channelopathy-associated insensitivity to pain. This condition can have significant implications for an individual's safety and quality of life, making early diagnosis vital.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and diagnostics. The cost of the test is set at 4400 AED. Through a comprehensive analysis of the patient's DNA, the test seeks to identify any genetic alterations in the SCN9A gene that may lead to the condition. This information can be crucial for the management and treatment of individuals with or at risk of developing this unique insensitivity to pain, allowing for tailored care plans and preventive measures to ensure their well-being.
The TFG Gene Hereditary Motor and Sensory Neuropathy Okinawa Type Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the TFG gene, which are responsible for the rare condition known as Hereditary Motor and Sensory Neuropathy Okinawa Type (HMSN Okinawa). This condition is characterized by a progressive loss of muscle tissue and touch sensation, primarily affecting the peripheral nervous system. The test is crucial for individuals with a family history of the disease or those exhibiting symptoms, providing essential information for managing and treating the condition effectively. The cost of the test is 4400 AED, reflecting the advanced genetic analysis involved in pinpointing the specific mutation within the TFG gene. By opting for this test at DNA Labs UAE, patients and their families can access vital genetic insights, paving the way for personalized treatment plans and interventions.
The TTN Gene Hereditary Myopathy with Early Respiratory Failure (HMERF) Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the TTN gene, which are associated with the development of HMERF. This condition is characterized by progressive muscle weakness, primarily affecting the skeletal muscles and leading to early respiratory failure due to diaphragmatic weakness. The test is crucial for individuals exhibiting symptoms of HMERF or those with a family history of the condition, as early detection can significantly impact management and treatment strategies.
Conducted through a blood sample, the test specifically looks for genetic abnormalities within the titin (TTN) gene, which plays a vital role in muscle elasticity and function. The accuracy and reliability of the test make it a valuable tool in the diagnosis of HMERF, enabling healthcare providers to tailor treatment plans to the individual's genetic profile.
The cost of the TTN Gene Hereditary Myopathy with Early Respiratory Failure Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations in the TTN gene, offering patients and their families critical insights into their condition and guiding future healthcare decisions.
